Nectar Lifescience Ltd
Nectar Lifesci. | 532649
Share Price Chart - Nectar Lifescience Ltd
Stock Performance
Ratios
About Company
- Nectar Lifescience Limited was initially incorporated on June 27, 1995 as 'Surya Medicare Limited'
- On March 26, 2004, Company changed the name from 'Surya Medicare Limited' to 'Nectar Lifescience Limited'
- NECLIFE is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products
- It is a global pharmaceutical company specializing in Cephalosporins
- Nectar excels in Cephalosporin APIs production with certified facilities meeting global standards
- Nectar has two manufacturing units with 13 facilities
- The Plant has a total oral and sterile capacity of more than 2000 MT
- All its facilities can be converted to multi-purpose plants based on product basket requirement
- Company is the world's leading producer of Cefixime Trihydrate, Cefuroxime Axetil, Cefpodoxime Proxetil and Sterile APIs
- Company's business operations are primarily concentrated on manufacturing and marketing of oral and sterile cephalosporins, phytochemicals and allied products
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Nectar Lifescience Ltd?
The current share price of Nectar Lifescience Ltd (Nectar Lifesci.) is ₹11.19. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Nectar Lifescience Ltd?
The Price-to-Earnings (P/E) ratio of Nectar Lifescience Ltd is 11.19. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Nectar Lifescience Ltd?
Nectar Lifescience Ltd has a 52-week high of ₹22.40 and a 52-week low of ₹9.30. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Nectar Lifescience Ltd?
Nectar Lifescience Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Nectar Lifescience Ltd?
The Earnings Per Share (EPS) of Nectar Lifescience Ltd is ₹-2.95. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Nectar Lifescience Ltd?
Nectar Lifescience Ltd has a Return on Equity (ROE) of -11.23%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
